Scott M. Wilhelm

15.9k total citations · 5 hit papers
70 papers, 9.0k citations indexed

About

Scott M. Wilhelm is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Scott M. Wilhelm has authored 70 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Surgery, 21 papers in Molecular Biology and 19 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Scott M. Wilhelm's work include Thyroid and Parathyroid Surgery (13 papers), Thyroid Cancer Diagnosis and Treatment (13 papers) and Parathyroid Disorders and Treatments (11 papers). Scott M. Wilhelm is often cited by papers focused on Thyroid and Parathyroid Surgery (13 papers), Thyroid Cancer Diagnosis and Treatment (13 papers) and Parathyroid Disorders and Treatments (11 papers). Scott M. Wilhelm collaborates with scholars based in United States, Germany and Italy. Scott M. Wilhelm's co-authors include Mark Lynch, Lila Adnane, Jacques Dumas, Philippa Newell, Augusto Villanueva, Josep M. Llovet, Dean Wilkie, Roger A. Smith, Charles Chen and Timothy B. Lowinger and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nature Reviews Drug Discovery.

In The Last Decade

Scott M. Wilhelm

68 papers receiving 8.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Discovery and development of sorafenib: a multikinase inhibitor for treating cancer

2006 1.4k citations Scott M. Wilhelm, Christopher Carter et al. Nature Reviews Drug Discovery profile →
Sorafenib Blocks the RAF/MEK/ERK Pathway, Inhibits Tumor Angiogenesis, and Induces Tumor Cell Apoptosis in Hepatocellular Carcinoma Model PLC/PRF/5

2006 1.3k citations Scott M. Wilhelm, Mark Lynch et al. Cancer Research profile →
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

2008 1.1k citations Scott M. Wilhelm, Lila Adnane et al. Molecular Cancer Therapeutics profile →
Regorafenib (BAY 73‐4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity

2010 1.0k citations Scott M. Wilhelm, Jacques Dumas et al. profile →
The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism

2016 770 citations Scott M. Wilhelm, Carmen C. Solórzano et al. profile →

Peers

Countries citing papers authored by Scott M. Wilhelm

Since Specialization

Citations

This map shows the geographic impact of Scott M. Wilhelm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott M. Wilhelm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott M. Wilhelm more than expected).

Fields of papers citing papers by Scott M. Wilhelm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott M. Wilhelm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott M. Wilhelm. The network helps show where Scott M. Wilhelm may publish in the future.

Co-authorship network of co-authors of Scott M. Wilhelm

This figure shows the co-authorship network connecting the top 25 collaborators of Scott M. Wilhelm. A scholar is included among the top collaborators of Scott M. Wilhelm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott M. Wilhelm. Scott M. Wilhelm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	What constitutes quality in endocrine surgery? Statement from the American Association of Endocrine Surgeons 2024 ·Surgery ·Aarti Mathur, Kepal N. Patel, Scott M. Wilhelm, Rebecca S. Sippel, Barbra S. Miller, Carmen C. Solórzano, Rachel R. Kelz	0
2	Timing of parathyroidectomy for tertiary hyperparathyroidism after kidney transplant 2024 ·Surgery ·(unknown), Scott M. Wilhelm	0
3	Pediatric thyroid cancer: Socioeconomic disparities and their impact on access to care 2023 ·Surgery ·(unknown), Scott M. Wilhelm	3
4	Primary hyperparathyroidism after radioactive iodine therapy: Is it a distinct clinical entity? 2022 ·The American Journal of Surgery ·Iuliana Bobanga, Judy Jin, Scott M. Wilhelm, Anuja L. Sarode, (unknown), (unknown), Christopher R. McHenry	2
5	A comparison of robotic and laparoscopic minimally invasive adrenalectomy for adrenal malignancies 2021 ·Surgical Endoscopy ·Jonathan J. Hue, (unknown), Katherine Bingmer, (unknown), John B. Ammori, Scott M. Wilhelm, Luke D. Rothermel, Christopher W. Towe	16
6	Outcomes of malignant pheochromocytoma based on operative approach: A National Cancer Database analysis 2021 ·Surgery ·Jonathan J. Hue, (unknown), (unknown), Scott M. Wilhelm, John B. Ammori, Christopher W. Towe, Luke D. Rothermel	8
7	The utility of frozen section examination for determining the extent of thyroidectomy in patients with a thyroid nodule and “atypia/follicular lesion of undetermined significance” 2014 ·The American Journal of Surgery ·(unknown), Scott M. Wilhelm, Christopher R. McHenry	12
8	Advances in management of thyroid cancer 2013 ·Current Problems in Surgery ·Judy Jin, Roy Phitayakorn, Scott M. Wilhelm, Christopher R. McHenry	12
9	Association of Thyroid, Breast and Renal Cell Cancer: A Population-based Study of the Prevalence of Second Malignancies 2012 ·Annals of Surgical Oncology ·(unknown), Scott M. Wilhelm, Jennifer L. Eaton, Christopher R. McHenry	47
10	Molecular Classification of Thyroid Nodules by Cytology 2008 ·The Laryngoscope ·Nitin A. Pagedar, Daniel Chen, Jay Wasman, P. Savvides, Mark Schluchter, Scott M. Wilhelm, Pierre Lavertu	9
11	Preclinical characterization of BAY 73-4506: A kinase inhibitor with broad spectrum antitumor activity targeting oncogenic and angiogenic kinases 2007 ·Molecular Cancer Therapeutics ·Scott M. Wilhelm, Lila Adnane, Claudia Hirth‐Dietrich, Paul H. Ehrlich, Mark Lynch	5
12	Outcomes of Pheochromocytoma Management in the Laparoscopic Era 2007 ·Annals of Surgical Oncology ·Carmen C. Solórzano, John I. Lew, Scott M. Wilhelm, William E. Sumner, Wendy Huang, (unknown), (unknown), Danny Sleeman, Richard A. Prinz	23
13	Analysis of transcription and protein expression changes in the 786-O human renal cell carcinoma tumor xenograft model in response to treatment with the multi-kinase inhibitor sorafenib (BAY 43-9006) 2006 ·Cancer Research ·Joan Levy, (unknown), Déborah Braun, Mary DeRome, (unknown), Hong Shi, Daniel C. Weaver, Yong S. Chang, Elizabeth Bortolon, Arris J. Henderson, (unknown), Amy Burd, James J. Elting, Mark Lynch, Sanjeeva Reddy, Scott M. Wilhelm	25
14	Discovery and development of sorafenib: a multikinase inhibitor for treating cancer breakdown → 2006 ·Nature Reviews Drug Discovery ·Scott M. Wilhelm, Christopher Carter, Mark Lynch, Timothy B. Lowinger, Jacques Dumas, Roger A. Smith, Brian Schwartz, Ronit Simantov, Susan L. Kelley	1447
15	Recent Advances in the Research and Development of RAF Kinase Inhibitors 2006 ·Current Topics in Medicinal Chemistry ·Roger A. Smith, Jacques Dumas, Lila Adnane, Scott M. Wilhelm	37
16	BAY 43-9006 Inhibition of Oncogenic RET Mutants 2006 ·JNCI Journal of the National Cancer Institute ·Francesca Carlomagno, Suresh Anaganti, Teresa Guida, Giuliana Salvatore, Giancarlo Troncone, Scott M. Wilhelm, Massimo Santoro	394
17	Discovery of a new class of p38 kinase inhibitors 2000 ·Bioorganic & Medicinal Chemistry Letters ·Jacques Dumas, Robert Sibley, Bernd Riedl, (unknown), Wendy Lee, Timothy B. Lowinger, Anikó M. Redman, Jeffrey S. Johnson, Jill Kingery-Wood, William J. Scott, Roger A. Smith, Mark A. Bobko, Robert Schoenleber, Gerald Ranges, Timothy J Housley, Ajay Bhargava, Scott M. Wilhelm, Alka Shrikhande	34
18	Endothelin up-regulation and localization following renal ischemia and reperfusion 1999 ·Kidney International ·Scott M. Wilhelm, Michael S. Simonson, Ann Robinson, Nicholas T. Stowe, James A. Schulak	98
19	Cold Ischemia Induces Endothelin Gene Upregulation in the Preserved Kidney 1999 ·Journal of Surgical Research ·Scott M. Wilhelm, Michael S. Simonson, Ann Robinson, Nicholas T. Stowe, James A. Schulak	17
20	Secreted Proteases 1990 ·Annals of the New York Academy of Sciences ·Gregory I. Goldberg, Steven M. Frisch, Chengshi He, Scott M. Wilhelm, Reuven Reich, Ivan E. Collier	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact